EUDA Health Holdings Limited (NASDAQ: EUDAW) Stock Competitors & Peer Comparison
See EUDAW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for EUDAW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EUDAW | $0.04 | +0.00% | 1.1M | 0.04 | $0.80 | N/A |
| HCA | $419.53 | +4.36% | 91.3B | 14.57 | $28.96 | +0.71% |
| THC | $264.38 | +2.05% | 21.7B | 15.61 | $17.24 | N/A |
| EHC | $120.71 | +0.20% | 12.1B | 20.82 | $5.84 | +0.63% |
| FMS | $22.33 | -0.53% | 12B | 8.39 | $2.66 | +3.87% |
| DVA | $182.00 | +1.08% | 11.7B | 14.30 | $12.80 | N/A |
| UHS | $171.97 | +0.04% | 10.6B | 7.80 | $22.54 | +0.45% |
| ENSG | $172.05 | +0.88% | 10B | 24.89 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $44.49 | +1.87% | 7.1B | 23.59 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
EUDAW vs HCA Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, HCA has a market cap of 91.3B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while HCA trades at $419.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas HCA's P/E ratio is 14.57. In terms of profitability, EUDAW's ROE is +1.20%, compared to HCA's ROE of -1.13%. Regarding short-term risk, EUDAW is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
EUDAW vs THC Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, THC has a market cap of 21.7B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while THC trades at $264.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas THC's P/E ratio is 15.61. In terms of profitability, EUDAW's ROE is +1.20%, compared to THC's ROE of +0.51%. Regarding short-term risk, EUDAW is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
EUDAW vs EHC Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while EHC trades at $120.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas EHC's P/E ratio is 20.82. In terms of profitability, EUDAW's ROE is +1.20%, compared to EHC's ROE of +0.25%. Regarding short-term risk, EUDAW is less volatile compared to EHC. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
EUDAW vs FMS Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, FMS has a market cap of 12B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while FMS trades at $22.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas FMS's P/E ratio is 8.39. In terms of profitability, EUDAW's ROE is +1.20%, compared to FMS's ROE of +0.07%. Regarding short-term risk, EUDAW is less volatile compared to FMS. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
EUDAW vs DVA Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, DVA has a market cap of 11.7B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while DVA trades at $182.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas DVA's P/E ratio is 14.30. In terms of profitability, EUDAW's ROE is +1.20%, compared to DVA's ROE of -1.24%. Regarding short-term risk, EUDAW is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
EUDAW vs UHS Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, UHS has a market cap of 10.6B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while UHS trades at $171.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas UHS's P/E ratio is 7.80. In terms of profitability, EUDAW's ROE is +1.20%, compared to UHS's ROE of +0.21%. Regarding short-term risk, EUDAW is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
EUDAW vs ENSG Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while ENSG trades at $172.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas ENSG's P/E ratio is 24.89. In terms of profitability, EUDAW's ROE is +1.20%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, EUDAW is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
EUDAW vs OSH Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas OSH's P/E ratio is -17.65. In terms of profitability, EUDAW's ROE is +1.20%, compared to OSH's ROE of +4.64%. Regarding short-term risk, EUDAW is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
EUDAW vs PACS Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, PACS has a market cap of 7.1B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while PACS trades at $44.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas PACS's P/E ratio is 23.59. In terms of profitability, EUDAW's ROE is +1.20%, compared to PACS's ROE of +0.27%. Regarding short-term risk, EUDAW is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
EUDAW vs CHE Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while CHE trades at $510.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas CHE's P/E ratio is 24.00. In terms of profitability, EUDAW's ROE is +1.20%, compared to CHE's ROE of +0.29%. Regarding short-term risk, EUDAW is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
EUDAW vs HIMS Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while HIMS trades at $27.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas HIMS's P/E ratio is -43.62. In terms of profitability, EUDAW's ROE is +1.20%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, EUDAW is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
EUDAW vs LHCG Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas LHCG's P/E ratio is 82.83. In terms of profitability, EUDAW's ROE is +1.20%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, EUDAW is less volatile compared to LHCG. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
EUDAW vs LFST Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while LFST trades at $13.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas LFST's P/E ratio is 95.05. In terms of profitability, EUDAW's ROE is +1.20%, compared to LFST's ROE of +0.03%. Regarding short-term risk, EUDAW is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
EUDAW vs CON Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while CON trades at $34.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas CON's P/E ratio is 21.50. In terms of profitability, EUDAW's ROE is +1.20%, compared to CON's ROE of +0.47%. Regarding short-term risk, EUDAW is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check CON's competition here
National HealthCare Corporation (AMEX: NHC)
EUDAW vs NHC Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, NHC has a market cap of 3.6B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while NHC trades at $224.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas NHC's P/E ratio is 29.09. In terms of profitability, EUDAW's ROE is +1.20%, compared to NHC's ROE of +0.13%. Regarding short-term risk, EUDAW is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
EUDAW vs OPCH Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, OPCH has a market cap of 3.5B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while OPCH trades at $23.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas OPCH's P/E ratio is 13.74. In terms of profitability, EUDAW's ROE is +1.20%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, EUDAW is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
EUDAW vs AMED Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AMED's P/E ratio is 39.30. In terms of profitability, EUDAW's ROE is +1.20%, compared to AMED's ROE of +0.11%. Regarding short-term risk, EUDAW is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
EUDAW vs AVAH Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AVAH has a market cap of 3.1B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AVAH trades at $13.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AVAH's P/E ratio is 20.62. In terms of profitability, EUDAW's ROE is +1.20%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, EUDAW is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
EUDAW vs BKD Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, BKD has a market cap of 2.9B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while BKD trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas BKD's P/E ratio is -20.94. In terms of profitability, EUDAW's ROE is +1.20%, compared to BKD's ROE of +4.06%. Regarding short-term risk, EUDAW is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check BKD's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
EUDAW vs GRDN Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, GRDN has a market cap of 2.7B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while GRDN trades at $42.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas GRDN's P/E ratio is 38.03. In terms of profitability, EUDAW's ROE is +1.20%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, EUDAW is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check GRDN's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
EUDAW vs ACHC Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while ACHC trades at $28.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas ACHC's P/E ratio is 14.17. In terms of profitability, EUDAW's ROE is +1.20%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, EUDAW is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check ACHC's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
EUDAW vs ADUS Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while ADUS trades at $117.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas ADUS's P/E ratio is 17.85. In terms of profitability, EUDAW's ROE is +1.20%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, EUDAW is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check ADUS's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
EUDAW vs MD Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while MD trades at $27.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas MD's P/E ratio is 12.09. In terms of profitability, EUDAW's ROE is +1.20%, compared to MD's ROE of +0.20%. Regarding short-term risk, EUDAW is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check MD's competition here
Select Medical Holdings Corporation (NYSE: SEM)
EUDAW vs SEM Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas SEM's P/E ratio is 15.43. In terms of profitability, EUDAW's ROE is +1.20%, compared to SEM's ROE of +0.08%. Regarding short-term risk, EUDAW is less volatile compared to SEM. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
EUDAW vs ASTH Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while ASTH trades at $38.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas ASTH's P/E ratio is 45.86. In terms of profitability, EUDAW's ROE is +1.20%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, EUDAW is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check ASTH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
EUDAW vs SNDA Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while SNDA trades at $39.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas SNDA's P/E ratio is -6.39. In terms of profitability, EUDAW's ROE is +1.20%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, EUDAW is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check SNDA's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
EUDAW vs SGRY Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, SGRY has a market cap of 1.8B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while SGRY trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas SGRY's P/E ratio is 36.21. In terms of profitability, EUDAW's ROE is +1.20%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, EUDAW is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
EUDAW vs AMEH Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AMEH's P/E ratio is 39.25. In terms of profitability, EUDAW's ROE is +1.20%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, EUDAW is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AMEH's competition here
Ardent Health Inc. (NYSE: ARDT)
EUDAW vs ARDT Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while ARDT trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas ARDT's P/E ratio is 8.98. In terms of profitability, EUDAW's ROE is +1.20%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, EUDAW is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check ARDT's competition here
Agilon Health, Inc. (NYSE: AGL)
EUDAW vs AGL Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AGL trades at $94.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AGL's P/E ratio is -6.09. In terms of profitability, EUDAW's ROE is +1.20%, compared to AGL's ROE of -1.19%. Regarding short-term risk, EUDAW is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AGL's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
EUDAW vs HCSG Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while HCSG trades at $21.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas HCSG's P/E ratio is 17.62. In terms of profitability, EUDAW's ROE is +1.20%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, EUDAW is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check HCSG's competition here
Innovage Holding Corp. (NASDAQ: INNV)
EUDAW vs INNV Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while INNV trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas INNV's P/E ratio is -122.56. In terms of profitability, EUDAW's ROE is +1.20%, compared to INNV's ROE of -0.01%. Regarding short-term risk, EUDAW is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check INNV's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
EUDAW vs PNTG Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while PNTG trades at $39.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas PNTG's P/E ratio is 30.00. In terms of profitability, EUDAW's ROE is +1.20%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, EUDAW is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
EUDAW vs NUTX Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, NUTX has a market cap of 1.4B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while NUTX trades at $196.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas NUTX's P/E ratio is 7.82. In terms of profitability, EUDAW's ROE is +1.20%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, EUDAW is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check NUTX's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
EUDAW vs AMN Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AMN trades at $33.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AMN's P/E ratio is 11.41. In terms of profitability, EUDAW's ROE is +1.20%, compared to AMN's ROE of +0.15%. Regarding short-term risk, EUDAW is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
EUDAW vs BKDT Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas BKDT's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, EUDAW is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
EUDAW vs USPH Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while USPH trades at $77.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas USPH's P/E ratio is 30.60. In terms of profitability, EUDAW's ROE is +1.20%, compared to USPH's ROE of -0.01%. Regarding short-term risk, EUDAW is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
EUDAW vs TALK Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas TALK's P/E ratio is 774.34. In terms of profitability, EUDAW's ROE is +1.20%, compared to TALK's ROE of +0.00%. Regarding short-term risk, EUDAW is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
EUDAW vs GMRS Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, GMRS has a market cap of 707.8M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while GMRS trades at $12.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas GMRS's P/E ratio is 5.82. In terms of profitability, EUDAW's ROE is +1.20%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, EUDAW is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
EUDAW vs EHAB Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas EHAB's P/E ratio is -197.14. In terms of profitability, EUDAW's ROE is +1.20%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, EUDAW is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
EUDAW vs STLN Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, STLN has a market cap of 628.9M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while STLN trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas STLN's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to STLN's ROE of +2.10%. Regarding short-term risk, EUDAW is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
EUDAW vs TOI Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas TOI's P/E ratio is -14.25. In terms of profitability, EUDAW's ROE is +1.20%, compared to TOI's ROE of +2.10%. Regarding short-term risk, EUDAW is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
EUDAW vs SRTA Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, SRTA has a market cap of 451.7M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while SRTA trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas SRTA's P/E ratio is -24.61. In terms of profitability, EUDAW's ROE is +1.20%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, EUDAW is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
EUDAW vs MCTA Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas MCTA's P/E ratio is 419.36. In terms of profitability, EUDAW's ROE is +1.20%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, EUDAW is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
EUDAW vs CYH Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, CYH has a market cap of 414.6M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while CYH trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas CYH's P/E ratio is 4.03. In terms of profitability, EUDAW's ROE is +1.20%, compared to CYH's ROE of +0.21%. Regarding short-term risk, EUDAW is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
EUDAW vs AUNA Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AUNA has a market cap of 384.2M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AUNA trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AUNA's P/E ratio is 4.68. In terms of profitability, EUDAW's ROE is +1.20%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, EUDAW is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
EUDAW vs VMD Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, VMD has a market cap of 333.7M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while VMD trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas VMD's P/E ratio is 24.33. In terms of profitability, EUDAW's ROE is +1.20%, compared to VMD's ROE of +0.10%. Regarding short-term risk, EUDAW is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
EUDAW vs CSU Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas CSU's P/E ratio is 0.67. In terms of profitability, EUDAW's ROE is +1.20%, compared to CSU's ROE of -0.33%. Regarding short-term risk, EUDAW is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
EUDAW vs AIRS Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AIRS has a market cap of 184.1M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AIRS trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AIRS's P/E ratio is -87.00. In terms of profitability, EUDAW's ROE is +1.20%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, EUDAW is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
EUDAW vs JYNT Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, JYNT has a market cap of 115.3M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while JYNT trades at $8.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas JYNT's P/E ratio is 80.90. In terms of profitability, EUDAW's ROE is +1.20%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, EUDAW is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
EUDAW vs FVE Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas FVE's P/E ratio is -5.64. In terms of profitability, EUDAW's ROE is +1.20%, compared to FVE's ROE of -0.15%. Regarding short-term risk, EUDAW is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
EUDAW vs KDLYW Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas KDLYW's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, EUDAW is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
EUDAW vs PARK Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, PARK has a market cap of 94.7M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while PARK trades at $20.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas PARK's P/E ratio is 28.35. In terms of profitability, EUDAW's ROE is +1.20%, compared to PARK's ROE of -0.18%. Regarding short-term risk, EUDAW is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
EUDAW vs BTMD Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, BTMD has a market cap of 64M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while BTMD trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas BTMD's P/E ratio is 13.18. In terms of profitability, EUDAW's ROE is +1.20%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, EUDAW is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
EUDAW vs ALR Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas ALR's P/E ratio is -1.11. In terms of profitability, EUDAW's ROE is +1.20%, compared to ALR's ROE of -0.15%. Regarding short-term risk, EUDAW is less volatile compared to ALR. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
EUDAW vs DCGO Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, DCGO has a market cap of 36.5M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while DCGO trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas DCGO's P/E ratio is -0.20. In terms of profitability, EUDAW's ROE is +1.20%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, EUDAW is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
EUDAW vs CCEL Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, CCEL has a market cap of 33.1M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while CCEL trades at $4.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas CCEL's P/E ratio is -13.70. In terms of profitability, EUDAW's ROE is +1.20%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, EUDAW is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
EUDAW vs IMAC Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas IMAC's P/E ratio is -2.27. In terms of profitability, EUDAW's ROE is +1.20%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, EUDAW is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
EUDAW vs PIII Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, PIII has a market cap of 28.2M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while PIII trades at $8.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas PIII's P/E ratio is -0.26. In terms of profitability, EUDAW's ROE is +1.20%, compared to PIII's ROE of +1.61%. Regarding short-term risk, EUDAW is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
EUDAW vs EUDA Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, EUDA has a market cap of 24.5M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while EUDA trades at $12.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas EUDA's P/E ratio is -24.74. In terms of profitability, EUDAW's ROE is +1.20%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, EUDAW is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
EUDAW vs CANO-WT Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, EUDAW is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
EUDAW vs AIH Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AIH's P/E ratio is -2.78. In terms of profitability, EUDAW's ROE is +1.20%, compared to AIH's ROE of +1.16%. Regarding short-term risk, EUDAW is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
EUDAW vs PIIIW Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, PIIIW has a market cap of 14.9M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas PIIIW's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, EUDAW is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO)
EUDAW vs CANO Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas CANO's P/E ratio is -0.01. In terms of profitability, EUDAW's ROE is +1.20%, compared to CANO's ROE of -1.49%. Regarding short-term risk, EUDAW is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
EUDAW vs FPCG Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas FPCG's P/E ratio is 0.09. In terms of profitability, EUDAW's ROE is +1.20%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, EUDAW is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
EUDAW vs AMS Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AMS's P/E ratio is -5.90. In terms of profitability, EUDAW's ROE is +1.20%, compared to AMS's ROE of -0.07%. Regarding short-term risk, EUDAW is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
EUDAW vs FTRP Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas FTRP's P/E ratio is -1.22. In terms of profitability, EUDAW's ROE is +1.20%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, EUDAW is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
EUDAW vs BMGL Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, BMGL has a market cap of 7.3M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while BMGL trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas BMGL's P/E ratio is -0.88. In terms of profitability, EUDAW's ROE is +1.20%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, EUDAW is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
EUDAW vs AIDX Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AIDX has a market cap of 6.9M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AIDX trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AIDX's P/E ratio is -1.06. In terms of profitability, EUDAW's ROE is +1.20%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, EUDAW is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
EUDAW vs MODV Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas MODV's P/E ratio is -0.03. In terms of profitability, EUDAW's ROE is +1.20%, compared to MODV's ROE of +1.36%. Regarding short-term risk, EUDAW is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
EUDAW vs GBNH Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas GBNH's P/E ratio is -0.06. In terms of profitability, EUDAW's ROE is +1.20%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, EUDAW is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
EUDAW vs RHE-PA Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, EUDAW's ROE is +1.20%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, EUDAW is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
EUDAW vs RHE Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas RHE's P/E ratio is -1.79. In terms of profitability, EUDAW's ROE is +1.20%, compared to RHE's ROE of -1.31%. Regarding short-term risk, EUDAW is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
EUDAW vs TOIIW Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, EUDAW's ROE is +1.20%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, EUDAW is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check TOIIW's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
EUDAW vs STLNW Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, STLNW has a market cap of 4M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while STLNW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas STLNW's P/E ratio is -0.13. In terms of profitability, EUDAW's ROE is +1.20%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, EUDAW is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check STLNW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
EUDAW vs IMACW Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas IMACW's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, EUDAW is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
EUDAW vs EDVA Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, EDVA has a market cap of 1.6M. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while EDVA trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas EDVA's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to EDVA's ROE of N/A. Regarding short-term risk, EUDAW is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check EDVA's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
EUDAW vs CCM Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, CCM has a market cap of 605.8K. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while CCM trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas CCM's P/E ratio is -0.28. In terms of profitability, EUDAW's ROE is +1.20%, compared to CCM's ROE of +0.06%. Regarding short-term risk, EUDAW is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
EUDAW vs NIVF Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while NIVF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas NIVF's P/E ratio is 0.56. In terms of profitability, EUDAW's ROE is +1.20%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, EUDAW is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
EUDAW vs NIVFW Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, NIVFW has a market cap of 43.2K. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, EUDAW's ROE is +1.20%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, EUDAW is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
EUDAW vs MNDR Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, MNDR has a market cap of 36.9K. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while MNDR trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas MNDR's P/E ratio is -0.04. In terms of profitability, EUDAW's ROE is +1.20%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, EUDAW is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
EUDAW vs TALKW Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas TALKW's P/E ratio is 0.00. In terms of profitability, EUDAW's ROE is +1.20%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, EUDAW is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check TALKW's competition here
DocGo Inc. (NASDAQ: DCGOW)
EUDAW vs DCGOW Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas DCGOW's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, EUDAW is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check DCGOW's competition here
New Frontier Health Corporation (NYSE: NFH)
EUDAW vs NFH Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, NFH has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas NFH's P/E ratio is -19.75. In terms of profitability, EUDAW's ROE is +1.20%, compared to NFH's ROE of -0.06%. Regarding short-term risk, EUDAW is less volatile compared to NFH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check NFH's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
EUDAW vs TVTY Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas TVTY's P/E ratio is 19.06. In terms of profitability, EUDAW's ROE is +1.20%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, EUDAW is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check TVTY's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
EUDAW vs ATIP-WT Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, EUDAW is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check ATIP-WT's competition here
Hanger, Inc. (NYSE: HNGR)
EUDAW vs HNGR Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas HNGR's P/E ratio is 19.71. In terms of profitability, EUDAW's ROE is +1.20%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, EUDAW is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check HNGR's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
EUDAW vs SLHGP Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, EUDAW's ROE is +1.20%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, EUDAW is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SLHGP's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
EUDAW vs DVCR Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas DVCR's P/E ratio is 28.34. In terms of profitability, EUDAW's ROE is +1.20%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, EUDAW is less volatile compared to DVCR. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check DVCR's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
EUDAW vs TLMDW Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas TLMDW's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, EUDAW is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check TLMDW's competition here
Almost Family Inc. (NASDAQ: AFAM)
EUDAW vs AFAM Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas AFAM's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +1.20%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, EUDAW is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
EUDAW vs TLMD Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas TLMD's P/E ratio is -1.60. In terms of profitability, EUDAW's ROE is +1.20%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, EUDAW is less volatile compared to TLMD. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check TLMD's competition here
Kindred Healthcare, Inc. (NYSE: KND)
EUDAW vs KND Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, KND has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas KND's P/E ratio is -1.14. In terms of profitability, EUDAW's ROE is +1.20%, compared to KND's ROE of -0.53%. Regarding short-term risk, EUDAW is less volatile compared to KND. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check KND's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
EUDAW vs SLHG Comparison September 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 1.1M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.04 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.04, whereas SLHG's P/E ratio is -1.48. In terms of profitability, EUDAW's ROE is +1.20%, compared to SLHG's ROE of N/A. Regarding short-term risk, EUDAW is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check SLHG's competition here